Search

Completely updated and revised, Nelson's Neonatal Antimicrobial Therapy, 2nd Edition, provides the most current, practical, and evidence-based recommendations for health care professionals treating neonates. Developed by leading experts in antimicrobial therapy, this resource aims to help clinicians select the right drug, dose, and duration for the treatment of bacterial, viral, fungal, and parasitic infections in neonates. Neonatal infectious disease therapeutics research continues to expand and respond to emerging novel pathogens and bacterial resistance. The recommendations in this book are based on the best available evidence to provide those taking care of neonates with the best possible treatment decisions, with updated guidance on dosing for low-birth-weight newborns, drug monographs for commonly prescribed drugs, and antimicrobial stewardship guidance for the nursery.

Completely updated and revised, the 30th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens. Free updates are available at aap.org/Nelsons. New in the 30th Edition Updated multiple drug-resistant gram-negative pathogens treatment recommendations with newly approved antibiotics Newer antibiotics, beyond vancomycin, to treat MRSA infections Updates on children's influenza, COVID-19, and enterovirus treatments Updates on travelers'diarrhea Latest guidelines for treatment of invasive pediatric fungal infections New guidelines for treatment of pediatric bacterial arthritis Recommendations on hepatitis C virus and cytomegalovirus treatment options CHAPTERS INCLUDE Antimicrobial Therapy According to Clinical Syndromes Antimicrobial Therapy for Neonates Choosing Among Antibiotics Antifungal Agents Antiviral Agents Antiparasitic Agents Preferred Therapy for Specific Bacterial and Mycobacterial Pathogens; Fungal Pathogens; Viral Pathogens; and Parasitic Pathogens Approach to Antibiotic Therapy for Drug-Resistant Gram-Negative Bacilli and Methicillin-Resistant Staphylococcus aureus Systemic and Topical Antimicrobial Dosing and Dose Forms Sequential Parenteral-Oral Antibiotic Therapy (Oral Step-Down Therapy) for Serious Infections Antimicrobial Prophylaxis/Prevention of Symptomatic Infection Approach to Antibiotic Allergies Antibiotic Stewardship Antibiotic Therapy for Children With Obesity And more…

Completely updated and revised, the 29th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices.Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens. CHAPTERS INCLUDE Antimicrobial Therapy According to Clinical SyndromesAntimicrobial Therapy for NeonatesChoosing AmongAntibioticsAntifungal AgentsAntiviral AgentsAntiparasitic AgentsOral Step-down Therapy for Serious InfectionsPrevention of Symptomatic InfectionApproach to Antibiotic AllergiesAntibiotic StewardshipAntibiotic Therapy for Children With Obesity

Completely updated and revised, the 28th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens. TOPICS INCLUDE Antimicrobial Therapy by Clinical SyndromesAntimicrobial Therapy for NeonatesChoosing AmongAntibioticsAntifungal AgentsAntiviral AgentsAntiparasitic AgentsOral Step-down Therapy for Serious InfectionsPrevention of Symptomatic InfectionApproach to Antibiotic AllergiesAntibiotic StewardshipNew in the 28th EditionUpdated recommendations on acute hematogenous osteomyelitis, based on newly published guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America, including information on a decrease in the incidence of MRSA infections, allowing the recommendation of cefazolin, again, in empiric therapy for most pediatric bone infectionsUpdated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022Ceftazidime/avibactam now preferred over fluoroquinolones for treatment of Klebsiella pneumoniae carbapenemase–producing enteric bacilli, if susceptibleCefiderocol, a new iron-binding siderophore cephalosporin class, recently approved in adults for treatment of many drug-resistant pathogens, particularly Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in childrenNew dosing for posaconazole suspension formulationNew approaches to mucormycosisAdded baloxavir for children 12+ years oldOnline updates of COVID-19 therapies once emergency use authorization in children at http://www.aap.org/nelsonsUpdated Nelson's app also available

Completely updated and revised, the 27th edition of this best-selling reference provides instant access to the latest recommendations for treatment of infectious diseases in children, including COVID-19. For each disease, the authors provide a commentary to help select the best of all antimicrobial choices. Drug descriptions cover all antimicrobial agents available today and include complete information about dosing regimens.New in the 27th edition:Continuous updates of drug and dosing changes available online at aap.org/Nelsons4 new chaptersReorganized chapter order to improve functionality

The 26th edition provides practical, evidence-based recommendations from the experts in antimicrobial therapy for treatment of infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobial agents available today and include complete information about dosing regimens.New in the 26th edition:First pediatric approval of beta-lactam/beta-lactamase inhibitor for CRE (carbapenem-resistant enteric bacilli), ceftazidime-avibactamReplacement antibiotics for cefotaxime (lack of availability in the US), including ceftriaxone and cefepime (for neonates)Situations in which ceftaroline is preferred over vancomycin by the Editors for MRSA infectionsUpdates on management of influenza, including baloxavir (now approved for children >12 years)New approaches to treatment of mucomycosisNew recommendations for malariaMore than 150 new references!

Nelson's Neonatal Antimicrobial Therapy is your go-to reference for treating neonates with infectious diseases. This handy reference provides evidence-based recommendations from leading experts in antimicrobial therapy for the treatment of infectious diseases in neonates.Get expert advice onDosing for neonates, including low-birth-weight newbornsDrug selection for bacterial, fungal, viral and parasitic pathogensDrug StewardshipAnd more

This best-selling and widely used resource on pediatric antimicrobial therapy provides instant access to reliable, up-to-the-minute recommendations for treatment of all infectious diseases in children. For each disease, the authors provide a commentary to help health care providers select the best of all antimicrobial choices. Drug descriptions cover pediatric-appropriate antimicrobials and include complete information about dosing regimens. In response to growing concerns about overuse of antibiotics, the program includes guidelines on when not to prescribe antibiotics.Now in color to help you find the best options quickly!New in the 25th edition: • Includes recommendations for new intravenous broad-spectrum beta-lactam/beta-lactamase inhibitor combinations. • Provides options for treatment of increasing resistance in Escherichia coli for urinary tract infections. • Includes updates for management of diarrhea, including recommendations for Giardia with tinidazole and nitazoxanide as drugs of choice, based on the new Infectious Diseases Society of America (IDSA) guidelines. • Clarifies specific, new, and evolving recommendations about antifungal therapeutic drug levels for several invasive fungal infections, particularly in immunocompromised children. • Reorganizes antiviral table for easier reading: common viral pathogens are in one table and HIV, hepatitis B, and hepatitis C are in a second table. • Provides guidance for neonates during the ongoing cefotaxime shortage, including alternatives to achieve similar antibacterial activity in similar tissue sites, with a similar safety profile. • Includes updates, such as new information on drug therapy and steroid therapy for neurocysticercosis, incorporating the new IDSA and American Society of Tropical Medicine and Hygiene guidelines. • Incorporates new IDSA coccidioidomycosis guidelines in updated recommendations. • Simplifies navigation with color-coded tabs and tables that make it easier to find the best treatment options for susceptibility of bacterial, fungal, viral, and parasitic pathogens.